On demand R&D
Thanks to our know-how and our expertise in molecular biology we develop kits for detection of the cancer-specific mutations that you needed within a collaborative framework. These products may later be commercially developed.
These kits are :
- usable in ddPCR
- with a sensitivity < 0,2%
- multiplexed, and therefore compatible with the detection of multiple mutations at the same time

For example :
Production of 3 multiplexed kits to detect mutations associated with the development of brain tumors, in collaboration with Pr D .Figarella-Branger, AP-HM, Marseille, FRANCE.

Brain tumor classification panel
Pediatric Brain tumor
FGFR1 mutations
FGFR1 duplication
BRAF mutations and fusion
PIK3CA mutations
H3F3A mutations
Available in October 2018
Adult Brain tumor
IDH1/2 mutations
EGFR / PDGFRa amplification
hTERT promotor mutations
PIK3CA mutations
H3F3A mutations
Available at the end of 2018
Brain tumor (CNV)
Co-Deletion 1p/19q
PTEN LOH
Chr7 trisomie
Available 1st quarter 2019
For example :
Production of 1 multiplexed kit to detect mutations associated with castration-resistant prostate cancer, in collaboration with Dr. PJ.Lamy, Labosud, Montpellier FRANCE.

Prostate cancer panel
Resistant to castration
AR mutations
AR amplification
Available 1st quarter 2019
